Fig. 5

d Representative immunoblots showing LC3 and Beclin-1 from HCT116 cells treated with either 2DG (5 mM) and different concentrations of lovastatin or lovastatin (10 μM) and different concentrations of 2DG for 48 h.

d Representative immunoblots showing LC3 and Beclin-1 from HCT116 cells treated with either 2DG (5 mM) and different concentrations of lovastatin or lovastatin (10 μM) and different concentrations of 2DG for 48 h.